At the beginning of the year, I profiled the ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO). It's a fund that is trying to carve out a unique niche in the biotechnology space by investing in those companies engaged in late stage clinical trials. By their very nature, these companies and the ETF itself are a high risk, high reward proposition but in its brief nine month history the fund has been able to deliver on its potential.
First off, let's review the investment criteria of the fund...
Click the button below to read the rest of this original article on Seeking Alpha.
ETF Research
We cover ETFs across all sectors, regions and markets. We analyze the portfolios themselves as well as the macro environments that affect them.
Mutual Fund Research
We do mutual fund research too! Although not covered quite as in-depth as the ETF world, we've still profiled many of the big names!
Investing Strategy
Everything from retirement planning to 401(k) investing to options trading strategies and everything in between!
Next Steps...
Got a question? A comment? A fund you want to see profiled? Let us know!
